Navigation Links
Lifeclinic to Feature Latest Health Stations at McKesson's Pharmacy of the Future
Date:7/3/2008

Lifeclinic International, Inc., the world's leading manufacturer and distributor of automated blood pressure monitors and health testing stations, will have its newest health station, the LC600 at the McKesson Pharmacy Strategies Conference. The Conference will be held at the Venetian Resort, Las Vegas, NV, July 7 - 10, 2008. The LC600 will be located in the Pharmacy of the Future while Lifeclinic's LC300 blood pressure monitor and LC500 health station will be in its booth, #941.

Burtonsville, MD (PRWEB) July 3, 2008 -- Lifeclinic International, Inc., the world's leading manufacturer and distributor of automated blood pressure monitors and health testing stations, will have its newest health station, the LC600 at the McKesson Pharmacy Strategies Conference. The Conference will be held at the Venetian Resort, Las Vegas, NV, July 7 - 10, 2008. The LC600 will be located in the Pharmacy of the Future while Lifeclinic's LC300 blood pressure monitor and LC500 health station will be in its booth, #941.

Featured at this year's Conference will be Lifeclinic's "Synergy," a comprehensive program that blends state-of-the-art hardware, software and value-added services, all designed to increase retail profits by building consumer loyalty and enhancing current and future revenue streams.

At the foundation of Synergy" is the LC600. This pharmacy-friendly Internet-connected health station offers automated blood pressure, weight, body fat and blood oxygen tests. The health station's scalability allows for the integration of additional tests from multiple manufacturers. Peripheral input ports include IR, USB a
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. CBS Outernet Partners With Lifeclinic International to Bring Interactive Health Programming and Advertising to Pharmacy Locations Nationwide
2. CBS Outernet and Lifeclinic To Show Wellness Channel at NACDS Marketplace
3. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
4. A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols
5. Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
6. Photo: Kyphon and the X-STOP(R) IPD(R) Procedure to be Featured on American Health Radio on Monday, September 24, 2007
7. Selective attention increases both gain and feature selectivity of the human auditory cortex
8. ABC TV San Francisco Features Canine Cancer Research Story: Saving Our Dogs, Helping Humans Beat Cancer - Work at Morris Animal Foundation, UC-Davis
9. Bradley Pharmaceuticals to Feature Elestrin(TM) at North American Menopause Society Annual Meeting
10. Women Deliver Conference to Feature United Nations Leaders
11. U.S. Census Bureau Daily Feature for September 29

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Biotech firm Replikins L...f the H1N1 virus genomic data. It shows that the ...f 3.7 (s.d. 4.5) during the virus,s current outbre...evels this week of 2.0 (s.d. 0.1). The H1N1 infect... Boston (PRWEB) November 27, 2009...
(Date:11/27/2009)..., , SAN FRANCISCO, Nov. 27 /PRNewswire-Firs...) announced that Blair Lambert, CFO/COO, will pres... will be held at the May Fair Hotel in London, Eng.... GMT. ,, To listen to a live broadcast of The ...net, please log on to www.gymboree.com, click on "...
(Date:11/27/2009)..., , NEUILLY-SUR-SEINE, France, Nov. 27 /...merican professional cycling team dedicated to eth...f cycling champions, announced today that it will ...f Transitions Optical as a new sponsor of the team...acturer of adaptive eyewear, offering the most adv...
(Date:11/27/2009)... XenaCare Holdings has an...he Arthritis Foundation, one of the largest nonpro...and public health education. , ...- XenaCare Holdings, Inc. (OTCBB: XCHO), a company...tion of consumer healthcare products, has announce...
(Date:11/27/2009)...Soaring rates to bring unprecedented medical, econ... Nov. 27 (HealthDay News) -- The number of people ...double over the next 25 years, a new study predict...t 44.1 million people with the disease, up from 23... of treating people with diabetes will triple, the...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3
... Privatizing water supplies is only a pretext for ...precious resources of the people at large, activis...orldwide in the bottled water market, corporations...ontrols one-third of the U.S. market and sells 70 ...
... A revolutionary new imaging technology is expecte...s. Elasticity imaging is an ultrasound technique r... measure the stiffness of tissue, relative to surr...psies turn up positive for cancer. In a re...
... Loading a Super Soaker (a brand of recreational ...ight, worse ejaculating on stuffed animals, how de... are heard these days after a popular 17-year-old .... A week or so later, Mayor Tish Colombi and ...
... New tuberculosis (TB) vaccines in development hav...strains of TB, including multidrug-resistant (MDR)...rald C. Sadoff, president and CEO of the Aeras Glo... solely to creating new TB vaccines, is working to...
... Additional beneficial effects on cardiometabolic ...s in trials of the anti-obesity drug rimonabant ma...e in the June issue of Drug and Therapeutics Bulle...n cardiometabolic risk factors are beyond those ex...
... Tobacco is perhaps the most common addiction all .... Alarmed by the devastating impact of tob...ld Health Organization is calling for stringent re...1 crore, according to WHO estimates. The ...
Other Medicine News:Health News:Multinationals Exploit Groundwater Sources, and People Suffer 2Health News:Multinationals Exploit Groundwater Sources, and People Suffer 3Health News:Multinationals Exploit Groundwater Sources, and People Suffer 4Health News:Multinationals Exploit Groundwater Sources, and People Suffer 5Health News:Beer Bashes of Teens Spinning Out of Control in US 2Health News:New TB Vaccines in Could Protect Against All Drug Resistant Strains 2Health News:New TB Vaccines in Could Protect Against All Drug Resistant Strains 3Health News:Anti-obesity Drugs Claimed Additional Benefits on cardiometabolic Risk Factors Questioned 2Health News:Tobacco Menace and What can Be Done About It 2Health News:Tobacco Menace and What can Be Done About It 3Health News:Tobacco Menace and What can Be Done About It 4
(Date:11/25/2009)...v. 25 Praxis Electronic Medical Re...n Academy of Family Physicians, (AAFP) Family Prac...urvey for improving medical quality, health mainte...w ARRA Stimulus legislation. Praxis also ranked #1... effect in determining their salary. Finally, Prax...
(Date:11/25/2009)... Pharmasset, Inc. (Nasda...y committed to discovering, developing and commerc...ported financial results for the fiscal year ended...set held $58.4 million in cash, cash equivalents a... and 2009 Highlights ,, RG7128 ,, Phase...
(Date:11/25/2009)... The FDA granted traditional appro...n-nucleoside reverse transcriptase inhibitor (NNRT...ated for use in treatment-experienced adults who a...ns resistant to an NNRTI and other antiretroviral ...n 48-week data from two Phase 3 studies known as D...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Measuring intellectual disability 8977 1Measuring intellectual disability 8977 2M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers 8975 1M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers 8975 2BD Announces CE Marking of BD ProbeTec 26amp 3B 238482 3B Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 49844 1BD Announces CE Marking of BD ProbeTec 26amp 3B 238482 3B Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 49844 2BD Announces CE Marking of BD ProbeTec 26amp 3B 238482 3B Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 49844 3BD Announces CE Marking of BD ProbeTec 26amp 3B 238482 3B Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 49844 4
...IEW, Calif., June 22, 2007 /PRNewswire/ -- MAP,Pha...esent Phase 2,data from its Unit Dose Budesonide (...the World Asthma Meeting at the Lutfi Kirdar,Conve... The oral and poster presentation entitled, "Effic...lation of budesonide for,nebulized delivery in a 6...
... Announces Bioinformatics Partnership with,Illumin...une 21, 2007,-GenoLogics, a leading developer of l... sciences research, today announced that,it has pe...technology partner and participant in IlluminaConn... by Illumina to advance,data integration and analy...
Other Medicine Technology:MAP Pharmaceuticals to Present Unit Dose Budesonide Phase 2,Clinical Data at the World Asthma Meeting 2GenoLogics Announces Bioinformatics Partnership with Illumina 2GenoLogics Announces Bioinformatics Partnership with Illumina 3
Shahinian Lacrimal Cannula
Solo-Care Multipurpose Solution
Graether Collar Button On Handle
Graether Irrigating Collar Button
Medicine Products: